Members |
targetComponentId |
hospitalsindlæggelse, overflytning fra andet hospital eller anden sundhedsinstitution |
Performance of the steps necessary to admit a patient to a hospital |
Hospital death disch. NOS |
Hospital death discharge notification |
Hospital death discharge NOS |
Patient deceased during stay (discharge status = dead) (finding) |
hospitalsfysiker |
Medical physicist |
Hospital physicist |
Medical physicist |
alopeci som følge af brug af hårstyling med varme |
Central centrifugal cicatricial alopecia (disorder) |
meget varme omgivelser |
Hot environment |
khoikhoi |
Khoisan language |
vaccine mod allergi over for husstøv |
House dust allergy vaccine (product) |
vaccine mod allergi over for husstøvmide |
House mite allergy vaccine (product) |
Bolig, ikke nærmere specificeret |
Housing ownership and tenure |
Housing NOS |
Housing ownership and tenure |
Housing lack NOS |
Housing lack |
Housing lack NOS |
Housing lack |
Human T-cell lymphotropic virus (HTLV) 3 antibody NOS |
Human immunodeficiency virus antibody titer measurement |
Human T-lymphotrophic virus antibody |
Human T-lymphotropic virus antibody |
Human adenovirus 40 antigen |
Antigen of Human mastadenovirus F (substance) |
Human adenovirus 41 antigen |
Antigen of Human mastadenovirus F (substance) |
human alpha1-proteinasehæmmer 1000 mg pulver til injektionsvæske, opløsning, hætteglas |
Human alpha1 proteinase inhibitor 1 g powder for solution for injection vial |
human alpha1-proteinasehæmmer 500 mg injektionsvæske, opløsning, hætteglas + diluent |
Human alpha1 proteinase inhibitor 500 mg powder for solution for injection vial |
Human alpha1 proteinase inhibitor 500mg powder for conventional release solution for injection vial |
Human alpha1 proteinase inhibitor 500 mg powder for solution for injection vial |
humant choriongonadotropin 10.000 IE pulver og solvent til injektionsvæske, opløsning, hætteglas |
Product containing precisely human chorionic gonadotropin 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
humant coronavirus HK1 |
Human coronavirus HKU1 |
Human epidermal growth factor 2 expressing colon and/or rectum malignant neoplasm |
Malignant neoplasm of colorectum expressing human epidermal growth factor 2 |
Human herpesvirus 1 group virus |
Simplexvirus |
Human herpesvirus 3 group virus |
Genus Varicellovirus (organism) |
Human immunodeficiency virus |
Human immunodeficiency virus Centers for Disease Control and Prevention stage 1 (finding) |
Human immunodeficiency virus (HIV) infection category B1 |
Human immunodeficiency virus Centers for Disease Control and Prevention stage 1 (finding) |
hiv, CDC-kategori A1 |
Human immunodeficiency virus Centers for Disease Control and Prevention stage 1 (finding) |
hiv, CDC-kategori B1 |
Human immunodeficiency virus Centers for Disease Control and Prevention stage 1 (finding) |
hiv, CDC-kategori C1 (aids) |
Human immunodeficiency virus Centers for Disease Control and Prevention stage 1 (finding) |
hiv-klasse I, WHO |
World Health Organization 2007 Human immunodeficiency virus infection clinical stage 1 |
hiv-klasse II, WHO |
World Health Organization 2007 Human immunodeficiency virus infection clinical stage 2 |
hiv-klasse III, WHO |
World Health Organization 2007 Human immunodeficiency virus infection clinical stage 3 (finding) |
hiv-klasse IV (aids), WHO |
World Health Organization 2007 Human immunodeficiency virus infection clinical stage 4 (finding) |
fund vedr. WHO-klassificering af hiv |
World Health Organization human immunodeficiency virus infection clinical stage (finding) |
hiv-seropositivitet |
Human immunodeficiency virus detected (finding) |
Human immunodeficiency virus type 2 |
Human immunodeficiency virus type 2 |
Human immunodeficiency virus type I |
Human immunodeficiency virus type I |
Human immunodeficiency virus, type II glycoprotein 53 antibody |
Human immunodeficiency virus 2 protein 53 antibody |
Humant immundefektvirus-associeret parodontit |
Periodontitis exacerbated by human immunodeficiency virus infection (disorder) |
Human immunoglobulin IgG 200mg/mL solution for injection |
Product containing only human immunoglobulin G (medicinal product) |
humant immunglobulin G 10 % injektionsvæske, opløsning, hætteglas |
Product containing only human immunoglobulin G (medicinal product) |
humant immunglobulin G 10 g injektionsvæske, opløsning, hætteglas |
Product containing only human immunoglobulin G (medicinal product) |
humant immunglobulin G 10 g pulver til injektionsvæske, opløsning, hætteglas |
Product containing only human immunoglobulin G (medicinal product) |
humant immunglobulin G 16 % injektionsvæske, opløsning, hætteglas |
Product containing precisely human immunoglobulin G 160 milligram/1 milliliter conventional release solution for injection (clinical drug) |
humant immunglobulin G 2,5 g pulver til injektionsvæske, opløsning, hætteglas |
Product containing only human immunoglobulin G (medicinal product) |
humant immunglobulin G 20 g injektionsvæske, opløsning, hætteglas |
Product containing only human immunoglobulin G (medicinal product) |
humant immunglobulin G 5 g pulver til injektionsvæske, opløsning, hætteglas |
Product containing only human immunoglobulin G (medicinal product) |
humant insulin 1 mg enkeltdosis, blister, tørt inhalationpulver |
Human insulin-containing product |
humant insulin 3 mg enkeltdosis, blister, tørt inhalationpulver |
Human insulin-containing product |
humant interferon gamma-1b 200 µg/ml injektionsvæske, opløsning, hætteglas a 0,5 ml |
Interferon gamma-1b 200 microgram/mL solution for injection |
bivirkning af humant interferon gamma-1b |
Adverse reaction to interferon gamma-1b |
Human leukocyte antigen A 3101 present |
Human leukocyte antigen A*31:01 detected (finding) |
humant leukocyt-antigen B1502 påvist |
HLA-B*15:02 detected |
humant leukocyt-antigen B 5701 påvist |
HLA-B*57:01 detected |
Human leukocyte antigen absent |
HLA antigen |
Human menopausal gonadotrophins 150iu injection |
Human menopausal gonadotropin only product |
Human menopausal gonadotrophins 150iu injection |
Human menopausal gonadotropin only product |
humane menopausale gonadotropiner 150 enheder (FSH) pulver til injektionsvæske, rekonstitution + solvent |
Human menopausal gonadotropin only product |
Human menopausal gonadotrophins 75iu injection |
Pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit powder for solution for injection vial |
Human menopausal gonadotrophins 75iu injection |
Pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit powder for solution for injection vial |
humane menopausale gonadotropiner 75 enheder (FSH) pulver og solvent til injektionsvæske, opløsning, hætteglas |
Pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit powder for solution for injection vial |
Human normal immunoglobulin 10g i-v infusion (pdr for recon) |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
humant normalt immunglobulin 10 g infusionsvæske, pulver + solvent til rekonstitution, til intravenøs anvendelse |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
humant normalt immunglobulin 10 g infusionsvæske, opløsning, hætteglas |
Product containing precisely human immunoglobulin G 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
humant normalt immunglobulin 12 g infusionsvæske, opløsning, hætteglas |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
humant normalt immunglobulin 16 % injektionsvæske, opløsning, hætteglas |
Product containing precisely human immunoglobulin G 160 milligram/1 milliliter conventional release solution for injection (clinical drug) |
humant normalt immunglobulin 1 g infusionsvæske, opløsning, hætteglas |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
Human normal immunoglobulin 2.5g i-v infusion (pdr for recon) |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
humant normalt immunglobulin 2,5 g pulver til injektionsvæske, rekonstitution + solvens til intravenøs anvendelse |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
humant normalt immunglobulin 2,5 g infusionsvæske, opløsning, hætteglas |
Product containing precisely human immunoglobulin G 2.5 gram/1 vial powder for conventional release solution for injection (clinical drug) |
humant normalt immunglobulin 250 mg injektionsvæske, opløsning, hætteglas |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
humant normalt immunglobulin 3 g infusionsvæske, opløsning, hætteglas |
Product containing precisely human immunoglobulin G 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Human normal immunoglobulin 500mg i-v infusion (pdr for recon) |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
humant normalt immunglobulin 500 mg pulver tilinfusionsvæske, rekonstitution + solvens, til intravenøs anvendelse |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
humant normalt immunglobulin 500 mg infusionsvæske, opløsning, hætteglas |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
Human normal immunoglobulin 5g i-v infusion (pdr for recon) |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
humant normalt immunglobulin 5 g pulver til infusionsvæske, rekonstitution + solvens, til intravenøs anvendelse |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
humant normalt immunglobulin 5 g infusionsvæske, opløsning, hætteglas |
Product containing precisely human immunoglobulin G 5 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Human normal immunoglobulin 6g conventional release solution for injection vial |
Human immunoglobulin G 6 G powder for solution for injection vial |
humant normalt immunglobulin 6 g infusionsvæske, opløsning, hætteglas |
Human immunoglobulin G 6 G powder for solution for injection vial |
humant normalt immunglobulin 750 mg injektionsvæske, opløsning, hætteglas |
Product containing only normal human immunoglobulin in parenteral dose form (medicinal product form) |
Human papilloma virus type 9 vaccine |
Vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens (medicinal product) |
Human papillomavirus group |
Human papillomavirus |
samtykke til test for humant papillomvirus afslået |
Screening for Human papillomavirus declined (situation) |
Human protein C 1000iu injection (pdr for recon)+solvent |
Product containing precisely human protein C 1000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
humant protein C 1000 IE pulver til injektionsvæske, rekonstitution + solvens |
Product containing precisely human protein C 1000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Human protein C 500iu injection (pdr for recon)+solvent |
Product containing precisely human protein C 500 unit/1 vial powder for conventional release solution for injection (clinical drug) |
humant protein C 500 IE pulver til injektionsvæske, rekonstitution + solvens |
Product containing precisely human protein C 500 unit/1 vial powder for conventional release solution for injection (clinical drug) |
anafylaksi fremkaldt af humanprotein |
Anaphylaxis |
humant rekombinant choriogonadotropin alfa 250 µg pulver til injektionsvæske, rekonstitution + solvens |
Choriogonadotropin alfa only product in parenteral dose form |
humant flåtbåren encefalit-immunglobulin injektionsvæske, opløsning, hætteglas a 1 ml |
Human tick borne encephalitis immunoglobulin only product in parenteral dose form |
humant flåtbåren encefalit-immunglobulin injektionsvæske, opløsning, hætteglas a 10 ml |
Human tick borne encephalitis immunoglobulin only product in parenteral dose form |
humant flåtbåren encefalit-immunglobulin injektionsvæske, opløsning, hætteglas a 2 ml |
Human tick borne encephalitis immunoglobulin only product in parenteral dose form |
humant flåtbåren encefalit-immunglobulin injektionsvæske, opløsning, hætteglas a 5 ml |
Human tick borne encephalitis immunoglobulin only product in parenteral dose form |
bløddelsfylder baseret på humant kollagen |
Skin fillers and protectives |
Human vaccination |
Active immunization |
humant vacciniaimmunglobulin 50 mg/ml injektionsvæske, opløsning, hætteglas a 50 ml |
Vaccinia human immune globulin 50 mg/mL solution for injection |
Humerus X-ray |
Plain X-ray of humerus (procedure) |
Humerus X-ray |
Plain X-ray of humerus (procedure) |